NCT03193359View on ClinicalTrials.gov

Open Label Study of BOTOX® (Botulinum Toxin Type A) as Headache Prophylaxis in Chinese Patients With Chronic Migraine

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

January 15, 2018

Primary Completion Date

September 9, 2021

Study Completion Date

September 9, 2021

Conditions
Migraine Disorders
Interventions
BIOLOGICAL

botulinum toxin Type A

Botulinum toxin Type A (BOTOX®) IM 155U to 195U injections in head/neck areas.

Sponsors

Lead Sponsor

Allergan
All Listed Sponsors
lead

Allergan

INDUSTRY